Eligibility Coronary Artery Disease NCT01593059

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
symptomatic coronary artery disease
Descrizione

ID.1

Tipo di dati

boolean

subject has signed informed consent for data release
Descrizione

ID.2

Tipo di dati

boolean

subject is geographically stable and willing to participate at all follow-up assessments
Descrizione

ID.3

Tipo di dati

boolean

subject is ≥ 18 years
Descrizione

ID.4

Tipo di dati

boolean

elective pci with des
Descrizione

ID.5

Tipo di dati

boolean

Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject did not sign informed consent for data release
Descrizione

ID.6

Tipo di dati

boolean

pregnancy
Descrizione

ID.7

Tipo di dati

boolean

known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation / antiplatelet therapy required for pci, stainless steel, sirolimus or contrast media
Descrizione

ID.8

Tipo di dati

boolean

planned surgery within 6 months of pci unless dual antiplatelet therapy will be maintained
Descrizione

ID.9

Tipo di dati

boolean

currently participating in another study and primary endpoint is not reached yet.
Descrizione

ID.10

Tipo di dati

boolean

Similar models

Eligibility Coronary Artery Disease NCT01593059

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
symptomatic coronary artery disease
boolean
ID.2
Item
subject has signed informed consent for data release
boolean
ID.3
Item
subject is geographically stable and willing to participate at all follow-up assessments
boolean
ID.4
Item
subject is ≥ 18 years
boolean
ID.5
Item
elective pci with des
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
subject did not sign informed consent for data release
boolean
ID.7
Item
pregnancy
boolean
ID.8
Item
known intolerance to aspirin, clopidogrel, ticlopidine, heparin or any other anticoagulation / antiplatelet therapy required for pci, stainless steel, sirolimus or contrast media
boolean
ID.9
Item
planned surgery within 6 months of pci unless dual antiplatelet therapy will be maintained
boolean
ID.10
Item
currently participating in another study and primary endpoint is not reached yet.
boolean